PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $15,000 | -63.4% | 34,581 | 0.0% | 0.00% | – |
| Q4 2015 | $41,000 | +17.1% | 34,581 | 0.0% | 0.00% | – |
| Q3 2015 | $35,000 | -22.2% | 34,581 | 0.0% | 0.00% | – |
| Q2 2015 | $45,000 | -4.3% | 34,581 | 0.0% | 0.00% | – |
| Q1 2015 | $47,000 | -4.1% | 34,581 | 0.0% | 0.00% | – |
| Q4 2014 | $49,000 | +2.1% | 34,581 | 0.0% | 0.00% | – |
| Q3 2014 | $48,000 | – | 34,581 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tappan Street Partners LLC | 11,593,530 | $7,049,000 | 20.61% |
| Bandera Partners LLC | 1,421,000 | $864,000 | 0.78% |
| Brown Advisory Securities, LLC | 580,000 | $353,000 | 0.08% |
| Sterling Global Strategies LLC | 20,000 | $12,000 | 0.06% |
| Freedom Investment Management, Inc. | 1,052,770 | $642,000 | 0.04% |
| BAXTER BROS INC | 150,500 | $92,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 576,897 | $351,000 | 0.01% |
| Ballentine Partners, LLC | 25,001 | $113,000 | 0.01% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 57,700 | $37,000 | 0.01% |
| Spark Investment Management LLC | 128,600 | $78,000 | 0.01% |